News
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.
WASHINGTON — The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is ...
If that’s the new policy, “you’d always be doing clinical trials and you’d never have a vaccine that was up to date.” The Novavax vaccine, which originally showed effectiveness in a ...
6don MSN
The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval commitment ...
It would be unethical to use a placebo, or to vaccinate some with an earlier version of Covid vaccines to show how well the updated version works. The Novavax vaccine is the only Covid shot on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results